AC
SRPT icon

AXQ Capital’s Sarepta Therapeutics SRPT Stock Holding History

AXQ Capital’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.14M Buy
98,212
+77,965
+385% +$1.51M 0.28% 97
2025
Q4 		$436K Buy
20,247
+5,628
+38% +$119K 0.1% 325
2025
Q3 		$282K Sell
14,619
-39,088
-73% -$697K 0.11% 336
2025
Q2 		$918K Buy
53,707
+40,878
+319% +$1.74M 0.3% 98
2025
Q1 		$819K Buy
+12,829
New +$1.35M 0.33% 89
2023
Q2 		– Sell
-10,900
Closed -$1.5M – 541
2023
Q1 		$1.5M Buy
+10,900
New +$1.41M 0.6% 27

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return